Filter
925
Text search:
adverse
drug
reactions
Featured
Recommendations
123
New Publications
257
Language
Document type
No document type
573
Guidelines
168
Studies & Reports
87
Manuals
52
Strategic & Response Plan
15
Fact sheets
11
Training Material
10
Brochures
3
Situation Updates
3
Resource Platforms
1
Infographics
1
Countries / Regions
India
70
Kenya
28
South Africa
28
Ethiopia
27
Tanzania
23
Western and Central Europe
21
Uganda
20
Global
20
Nigeria
18
Zambia
17
Malawi
16
Nepal
15
Ghana
14
Philippines
10
Bangladesh
10
Namibia
10
Latin America and the Carribbean
10
Eastern Europe
10
Zimbabwe
9
Cambodia
9
Sierra Leone
8
Liberia
8
Myanmar / Burma
8
Africa
7
Rwanda
6
Botswana
6
Eswatini/ Swaziland
5
South–East Asia Region
5
USA
4
South Sudan
3
Germany
3
Syria
3
Indonesia
3
Brazil
3
Ukraine
3
Sri Lanka
3
Western Pacific Region
3
Congo, Democratic Republic of
2
Haiti
2
Thailand
2
Argentina
2
Colombia
2
Bolivia
2
Lesotho
2
Asia
2
Timor Leste/ East Timor
2
Russia
2
Senegal
1
Mali
1
Cameroon
1
Iraq
1
Lebanon
1
Chad
1
Gambia
1
China
1
Ireland
1
Mozambique
1
Benin
1
Angola
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Fiji
1
Solomon Islands
1
Bhutan
1
North Korea
1
Laos
1
Australia
1
Georgia
1
Vietnam
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
359
Clinical Guidelines
133
Public Health
45
Women & Child Health
26
Key Resources
18
Capacity Building
13
Pharmacy & Technologies
12
Toolboxes
TB
135
Mental Health
79
HIV
78
Pharmacy
66
NTDs
50
COVID-19
34
AMR
27
Caregiver
18
Ebola & Marburg
17
Malaria
16
NCDs
14
Refugee
10
Polio
8
Conflict
8
Rapid Response
7
Specific Hazards
5
Natural Hazards
4
Planetary Health
4
Disability
3
Cholera
3
Zika
3
Global Health Education
3
2.0 Rapid Response
3
Health Financing Toolbox
1
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention an
...
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on
...
An update from the EU Early Warning System
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner
...
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of residual infections in disease endemic districts pose
...
with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of products granted marketing authorization in Ghana.
